SOLENO THERAPEUTICS INC - COM NEW (SLNO) Institutional Ownership

13F Institutional Holders and Ownership History from Q4 2017 to Q3 2024

Type / Class
Equity / COM NEW
Symbol
SLNO on Nasdaq
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of SOLENO THERAPEUTICS INC - COM NEW (SLNO) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2024 Q3 0 $0 -$22,440,000 0
2024 Q2 550,000 $22,440,000 $40.80 1
2024 Q1 550,000 $23,540,000 +$23,540,000 $42.80 1
2022 Q4 0 $0 -$171,000 0
2022 Q3 102,288 $171,000 -$7,972,004 $1.71 2
2022 Q2 45,124,008 $8,114,889 -$1,156,077 $0.18 31
2022 Q1 47,000,490 $11,190,224 +$4,214,720 $0.22 33
2021 Q4 27,947,522 $11,456,477 -$308,174 $0.41 32
2021 Q3 28,482,131 $26,310,750 -$433,787 $0.92 34
2021 Q2 28,693,690 $32,604,902 -$3,739,276 $1.14 45
2021 Q1 31,797,413 $40,064,019 -$21,783,660 $1.26 61
2020 Q4 43,853,865 $84,634,096 -$1,404,030 $1.93 66
2020 Q3 43,259,416 $108,407,686 +$2,780,846 $2.51 63
2020 Q2 42,510,320 $94,267,393 +$48,279,318 $2.22 61
2020 Q1 20,559,947 $48,027,998 +$7,603,244 $2.38 29
2019 Q4 17,217,846 $50,048,000 +$20,745,834 $2.94 17
2019 Q3 10,061,469 $14,999,000 -$12,301,893 $1.50 16
2019 Q2 14,396,065 $39,357,000 +$58,058 $2.80 17
2019 Q1 14,397,730 $29,666,000 -$648,361 $2.06 20
2018 Q4 14,803,113 $25,298,000 +$10,138,667 $1.71 16
2018 Q3 8,849,455 $19,113,000 +$107,819 $2.16 14
2018 Q2 8,796,506 $20,582,000 +$1,058,898 $2.34 16
2018 Q1 8,370,203 $15,171,000 +$170,912 $1.81 8
2017 Q4 8,275,469 $14,896,000 +$14,896,000 $1.80 9